Relief Therapeutics and NeuroRx expand clinical trial of RLF-100 to all patients with critical Covid-19 and respiratory failure

Relief Therapeutics and NeuroRx have expanded clinical trial of RLF-100 to all patients with critical Covid-19 and respiratory failure. (Credit: Pete Linforth from Pixabay)